Top

Current Pulmonology Reports

Published in:

01-06-2017 | Sleeping and Breathing (T Lee-Chiong, Section Editor)

Screening Programs for Obstructive Sleep Apnea

Authors: Virginia S. de Los Reyes, Cecilia A. Jimeno, Vincent Anthony S. Tang, Patricia Marie M. Lusica

Published in: Current Pulmonology Reports | Issue 2/2017

Abstract

Purpose of the Review

The aim of this article is to describe the literature on the rationale, methods, and outcomes of screening programs for obstructive sleep apnea (OSA).

Recent Findings

The evidence does not support screening for OSA in the general population. Instead, targeted case finding is advised among the following high-risk groups: patients with obesity, congestive heart failure, atrial fibrillation, treatment refractory hypertension, type 2 diabetes, stroke, nocturnal dysrhythmias, and pulmonary hypertension. However, the method of screening remains unclear with some studies suggesting the use of questionnaires to identify risk for OSA prior to polysomnography (PSG), while others recommend 2-step screening involving questionnaires and portable monitors. Commercial motor vehicle (CMV) drivers should undergo universal screening.

Summary

There is a clear rationale for screening, and target populations for screening have been identified. However, the method of screening is not yet clear. Randomized trials should be done to compare the outcomes of screening versus no screening for OSA among the high-risk populations.

Public Health England. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. 2015. Available online: https://www.gov.uk/government/publications/evidence-review-criteria-national-screening-programmes/criteria-for-appraising-the-viability-effectiveness-and-appropriateness-of-a-screening-programme

Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–14. doi:10.1093/aje/kws342.CrossRefPubMedPubMedCentral

Young T, Palta M, Dempsey J, et al. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ. 2009;108(5):246–9.PubMedPubMedCentral

Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–41.CrossRef

Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA. 2000;283:1829–36.CrossRef

Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746–52.CrossRef

Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006;28:596–602. doi:10.1183/09031936.06.00107805.CrossRefPubMed

Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–41.CrossRef

Kylintireas I, Craig S, Nethononda R, Kohler M, Francis J, Choudhury R, et al. Atherosclerosis and arterial stiffness in obstructive sleep apnea—A cardiovascular magnetic resonance study. Atherosclerosis. 2012;222:483–9. doi:10.1056/NEJMoa043104.CrossRefPubMedPubMedCentral

10.

Doonan RJ, Scheffler P, Lalli M, Kimoff RJ, Petridou ET, Daskalopoulos ME, et al. Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res. 2011;34:23–32.CrossRef

11.

Hoffstein V, Mateika S. Cardiac-arrhythmias, snoring, and sleep-apnea. Chest. 1994;106:466–71.CrossRef

12.

Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleepdisordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910–6. doi:10.1164/rccm.200509-1442OC.CrossRefPubMedPubMedCentral

13.

Gottlieb DJ, Yenokyan G, Newman AB, O’Connor GT, Punjabi NM, Quan SF, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure the sleep heart health study. Circulation. 2010;122:352–60. doi:10.1161/CIRCULATIONAHA.109.901801.CrossRefPubMedPubMedCentral

14.

Chung F, Elsaid H. Screening for obstructive sleep apnea before surgery: why is it important? Curr Opi Anesthesiol. 2009;22:405–11. doi:10.1097/ACO.0b013e32832a96e2.CrossRef

15.

Liao P, Yegneswaran B, Vairavanathan S, Ziberman P, Chung F, et al. Postoperative complications in patients with obstructive sleep apnea: a retrospective matched cohort study. Canadian J Anaesth. 2009;56:819–28. doi:10.1007/s12630-009-9190-y.CrossRef

16.

Ravesloot MJL, van Maanen JP, Hilgevoord AAJ, Van Wagensveld BA, de Vries N. Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol. 2012;269:1865–71. doi:10.1007/s00405-012-1948-0.CrossRefPubMedPubMedCentral

17.

Balk EM, Moorthy D, Obadan NO, et al. Diagnosis and treatment of obstructive sleep apnea in adults [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jul. (Comparative Effectiveness Reviews, No. 32.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK63560/

18.

Screening for obstructive sleep apnea in adults: an evidence review for the U.S. Preventive Services Task Force AHRQ Publication No. 14–05216-EF-1 June 2016

19.

Horstmann S, Hess CW, Bassetti C, et al. Sleepiness-related accidents in sleep apnea patients. Sleep. 2000;23(3):383–9.CrossRef

20.

Quan SF, Wright R, Baldwin CM, et al. Obstructive sleep apnea-hypopnea and neurocognitive functioning in the sleep heart health study. Sleep Med. 2006;6:498–507.CrossRef

21.

Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217–39.CrossRef

22.

Victor LD. Obstructive sleep apnea. Am Fam Physician. 1999;60:2279–86.PubMed

23.

Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5. doi:10.1056/NEJM199304293281704.CrossRef

24.

Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, Boehlecke B, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29:375–80.CrossRef

25.

Montesi SB, Edwards BA, Malhotra A, Bakker JP. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. JClin Sleep Med. 2012;8(5):587–96. doi:10.5664/jcsm.2170.CrossRef

26.

Chen L, Pei J-H, Chen H-M. Effects of continuous positive airway pressure treatment on glycaemic control and insulin sensitivity in patients with obstructive sleep apnoea and type 2 diabetes: a meta-analysis. Arch Med Sci. 2014;10(4):637–42. doi:10.5114/aoms.2014.44854.CrossRefPubMedPubMedCentral

27.

Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–53. doi:10.1016/S0140-6736(05)71141-7.CrossRefPubMed

28.

Ellen RL, Marshall SC, Palayew M, Molnar FJ, Wilson KG, Man-Son-Hing M. Systematic review of motor vehicle crash risk in persons with sleep apnea. J Clin Sleep Med. 2006;2:193–200.PubMed

29.

Tanaka S, Shima M. Assessment of screening tests for sleep apnea syndrome in the workplace. J Occup Health. 2010;52:99–105.CrossRef

30.

Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–3.CrossRef

31.

Morales CR, Hurley S, Wick LC, Staley B, Pack FM, Gooneratne NS, et al. In-home, self-assembled sleep studies are useful in diagnosing sleep apnea in the elderly. Sleep. 2012;35:1491–501. doi:10.5665/sleep.2196.CrossRefPubMedPubMedCentral

32.

Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. Can J Anaesth. 2010;57:423–38. doi:10.1007/s12630-010-9280-x.CrossRefPubMed

33.

Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. Validation of the Berlin questionnaire and American Society of Anesthesiologists checklist as screening tools for obstructive sleep apnea in surgical patients. Anesthesiology. 2008;108:822–30. doi:10.1097/ALN.0b013e31816d91b5.CrossRefPubMed

34.

Silva GE, Vana KD, Goodwin JL, Sherrill DL, Quan SF. Identification of patients with sleep disordered breathing: comparing the four-variable screening tool, STOP, STOP-Bang, and Epworth Sleepiness Scales. J Clin Sleep Med. 2011;7:467–72. doi:10.5664/JCSM.1308.CrossRefPubMedPubMedCentral

35.

•• Hrubos-Strom H, Randby A, Namtvedt SK, et al. A Norwegian population-based study on the risk and prevalence of obstructive sleep apnea. The Akershus Sleep Apnea Project (ASAP). J Sleep Res. 2011;201:162–70. doi:10.1111/j.1365-2869.2010.00861.x. The conclusion of this study is that the screening properties of the Berlin Questionnaire are suboptimal in a large sample of randomly selected respondents from the general Norwegian population CrossRef

36.

• Burgess KR, Havryk A, Newton S, Tsai WH, Whitelaw WA. Targeted case finding for OSA within the primary care setting. J Clin Sleep Med. 2013;9(7):681–6. doi:10.5664/jcsm.2838. In this community screening of 1157 individuals, high-risk patients that may be targeted for screening for OSA are those with BMI > 30, type 2 diabetes, treated hypertension, and ischemic heart disease because of the high prevalence of OSA in this population CrossRefPubMedPubMedCentral

37.

Gurubhagavatula I, Fields BG, Morales CR, et al. Screening for severe obstructive sleep apnea syndrome in hypertensive outpatients. J Clin Hypertens (Greenwich). 2013;15(4):279–88. doi:10.1111/jch.12073.CrossRef

38.

Westlake K, Plihalova A, Pretl M, Lattova Z, Polak J. Screening for obstructive sleep apnea syndrome in patients with type 2 diabetes mellitus: a prospective study on sensitivity of Berlin and STOP-Bang questionnaires. Sleep Med. 2016;26:71–6. doi:10.1016/j.sleep.2016.07.009.CrossRefPubMed

39.

Berger M, Varvarigou V, Rielly A, Czeisler CA, Malhotra A, Kales SN. Employer-mandated sleep apnea screening and diagnosis in commercial drivers. J Occup Environ Med. 2012;54:1017–25. doi:10.1097/JOM.0b013e3182572e16.CrossRefPubMedPubMedCentral

40.

• Platt AB, Wick LC, Hurley S, Soto-Calderon H, Wieland W, Staley B, Masilin G, et al. Hits and misses: screening commercial drivers for obstructive sleep apnea using guidelines recommended by a joint task force. JOEM. 2013;55(9):1035–40. doi:10.1097/JOM.0b013e318298fb0e. This study showed that the high burden of OSA combined with the good performance of the screening tools supports universal screening of all commercial drivers CrossRefPubMed

41.

Hoffman B, Wingenbach DD, Kagey AN, Schaneman JL, Kasper D. The long-term health plan and disability cost benefit of obstructive sleep apnea treatment in a commercial motor vehicle driver population. J Occup Environ Med. 2010;52:473–7. doi:10.1097/JOM.0b013e3181dbc8ab.CrossRefPubMed

42.

Bahammam A, Delaive K, Ronald J, Manfreda J, Roos L, Kryger MH. Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep. 1999;22:740–7.CrossRef

43.

Kuna ST, Gurubhagavatula I, Maislin G, et al. Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea. Am J Respir Crit Care Med. 2011;183:1238–44. doi:10.1164/rccm.201011-1770OC.CrossRefPubMed

44.

Cawley MJ, Warning 2nd WJ. A systematic review of pharmacists performing obstructive sleep apnea screening services. Int J Clin Pharm. 2016;38(4):752–60. doi:10.1007/s11096-016-0319-0.CrossRefPubMed

45.

Mold JW, Quattlebaum C, Schinnerer E, et al. Identification by primary care clinicians of patients with obstructive sleep apnea: a practice-based research network (PBRN) study. J Am Board Fam Med. 2011;2:138–45. doi:10.3122/jabfm.2011.02.100095.CrossRef

46.

Hayes SM, Murray S, Castriotta RJ, et al. (Mis) perceptions and interactions of sleep specialists and generalists: obstacles to referrals to sleep specialists and the multidisciplinary team management of sleep disorders. J Clin Sleep Med. 2012;8(6):633–42. doi:10.5664/jcsm.2252.CrossRefPubMedPubMedCentral

Title: Screening Programs for Obstructive Sleep Apnea
Authors: Virginia S. de Los Reyes
Cecilia A. Jimeno
Vincent Anthony S. Tang
Patricia Marie M. Lusica
Publication date: 01-06-2017
Publisher: Springer US
Published in: Current Pulmonology Reports / Issue 2/2017
Electronic ISSN: 2199-2428
DOI: https://doi.org/10.1007/s13665-017-0170-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of the Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 2/2017

Traumatic Brain Injury in Combat Trauma

Non-traumatic Pulmonary Emergencies in the Deployed Setting

Combat Venous Thromboembolism

Overlap Syndrome

Hypoventilation Syndromes

Sleep-Related Breathing Disorders and Cancer

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials